tetano
Editor, Senior Moderator
JAMA Netw Open
. 2025 Jun 2;8(6):e2518648.
doi: 10.1001/jamanetworkopen.2025.18648. COVID-19 and Cognitive Change in a Community-Based Cohort
Ryan T Demmer[SUP] 1 2 3 [/SUP], Talea Cornelius[SUP] 4 [/SUP], Zarina Kraal[SUP] 5 [/SUP], James R Pike[SUP] 6 [/SUP], Yifei Sun[SUP] 7 [/SUP], Pallavi Balte[SUP] 4 [/SUP], Chaoqi Wu[SUP] 4 [/SUP], Norrina B Allen[SUP] 8 [/SUP], Mary Cushman[SUP] 9 10 [/SUP], Astrid M Suchy-Dicey[SUP] 11 [/SUP], Mitchell S V Elkind[SUP] 5 2 [/SUP], Virginia Howard[SUP] 12 [/SUP], Anna Kucharska-Newton[SUP] 13 [/SUP], Deb Levine[SUP] 14 [/SUP], Pamela L Lutsey[SUP] 3 [/SUP], Jennifer Manly[SUP] 5 [/SUP], Thomas H Mosley[SUP] 15 [/SUP], Priya Palta[SUP] 16 [/SUP], Melinda C Power[SUP] 17 [/SUP], Sudha Seshadri[SUP] 18 [/SUP], Russell P Tracy[SUP] 10 [/SUP], Keenan Walker[SUP] 19 [/SUP], Josef Coresh[SUP] 20 21 [/SUP], Elizabeth C Oelsner[SUP] 4 [/SUP]
Affiliations
Importance: SARS-CoV-2 infection has been linked to neurotoxic effects and cognitive deficits.
Objective: To determine whether decreases in cognitive function were accelerated after SARS-CoV-2 infection compared with individuals not infected.
Design, setting, and participants: Multicenter, prospective cohort study from 2016 to 2022 among 3525 participants alive on March 1, 2020, and enrolled in The Atherosclerosis Risk in Communities (ARIC) study and the Collaborative Cohort of Cohorts for COVID-19 Research study who completed a prepandemic cognitive assessment and a pandemic-era assessment of SARS-CoV-2 infection. Final analyses performed in November 2024.
Exposure: SARS-CoV-2 infection determined via self-report of a positive SARS-CoV-2 test or health care professional diagnosis of COVID-19, a positive SARS-CoV-2 antinucleocapsid antibody response, or presence of an administrative code for COVID-19 on medical records.
Main outcomes and measures: A neuropsychological battery assessed multiple cognitive domains, and a cocalibrated confirmatory factor analysis generated factor scores for global cognitive function. The primary outcome was the rate of excess change in cognitive function.
Results: The 3525 eligible participants had a mean (SD) age of 80.8 (4.7) years, 2085 (59.1%) were female, 752 (21.4%) were Black, and 2773 (78.6%) were White. SARS-CoV-2 infection was detected among 307 participants (8.7%), 103 of whom (33.6%) were hospitalized. Among uninfected participants, the mean annualized change in cognitive function was -0.09 (95% CI, -0.13 to -0.04). Compared with this rate, change was faster (β = -0.06; 95% CI, -0.09 to -0.02) among participants hospitalized for infection, but not different from participants who were infected but not hospitalized (β = 0.00; 95% CI, -0.02 to 0.03). The association among participants hospitalized for infection was evident in the cognitive domains of memory and executive function, but not language.
Conclusions and relevance: This cohort study of older participants found accelerated decreases in cognition among individuals hospitalized for SARS-CoV-2 infection, but not nonhospitalized infection, in comparison with individuals not yet infected.
. 2025 Jun 2;8(6):e2518648.
doi: 10.1001/jamanetworkopen.2025.18648. COVID-19 and Cognitive Change in a Community-Based Cohort
Ryan T Demmer[SUP] 1 2 3 [/SUP], Talea Cornelius[SUP] 4 [/SUP], Zarina Kraal[SUP] 5 [/SUP], James R Pike[SUP] 6 [/SUP], Yifei Sun[SUP] 7 [/SUP], Pallavi Balte[SUP] 4 [/SUP], Chaoqi Wu[SUP] 4 [/SUP], Norrina B Allen[SUP] 8 [/SUP], Mary Cushman[SUP] 9 10 [/SUP], Astrid M Suchy-Dicey[SUP] 11 [/SUP], Mitchell S V Elkind[SUP] 5 2 [/SUP], Virginia Howard[SUP] 12 [/SUP], Anna Kucharska-Newton[SUP] 13 [/SUP], Deb Levine[SUP] 14 [/SUP], Pamela L Lutsey[SUP] 3 [/SUP], Jennifer Manly[SUP] 5 [/SUP], Thomas H Mosley[SUP] 15 [/SUP], Priya Palta[SUP] 16 [/SUP], Melinda C Power[SUP] 17 [/SUP], Sudha Seshadri[SUP] 18 [/SUP], Russell P Tracy[SUP] 10 [/SUP], Keenan Walker[SUP] 19 [/SUP], Josef Coresh[SUP] 20 21 [/SUP], Elizabeth C Oelsner[SUP] 4 [/SUP]
Affiliations
- PMID: 40587126
- DOI: 10.1001/jamanetworkopen.2025.18648
Importance: SARS-CoV-2 infection has been linked to neurotoxic effects and cognitive deficits.
Objective: To determine whether decreases in cognitive function were accelerated after SARS-CoV-2 infection compared with individuals not infected.
Design, setting, and participants: Multicenter, prospective cohort study from 2016 to 2022 among 3525 participants alive on March 1, 2020, and enrolled in The Atherosclerosis Risk in Communities (ARIC) study and the Collaborative Cohort of Cohorts for COVID-19 Research study who completed a prepandemic cognitive assessment and a pandemic-era assessment of SARS-CoV-2 infection. Final analyses performed in November 2024.
Exposure: SARS-CoV-2 infection determined via self-report of a positive SARS-CoV-2 test or health care professional diagnosis of COVID-19, a positive SARS-CoV-2 antinucleocapsid antibody response, or presence of an administrative code for COVID-19 on medical records.
Main outcomes and measures: A neuropsychological battery assessed multiple cognitive domains, and a cocalibrated confirmatory factor analysis generated factor scores for global cognitive function. The primary outcome was the rate of excess change in cognitive function.
Results: The 3525 eligible participants had a mean (SD) age of 80.8 (4.7) years, 2085 (59.1%) were female, 752 (21.4%) were Black, and 2773 (78.6%) were White. SARS-CoV-2 infection was detected among 307 participants (8.7%), 103 of whom (33.6%) were hospitalized. Among uninfected participants, the mean annualized change in cognitive function was -0.09 (95% CI, -0.13 to -0.04). Compared with this rate, change was faster (β = -0.06; 95% CI, -0.09 to -0.02) among participants hospitalized for infection, but not different from participants who were infected but not hospitalized (β = 0.00; 95% CI, -0.02 to 0.03). The association among participants hospitalized for infection was evident in the cognitive domains of memory and executive function, but not language.
Conclusions and relevance: This cohort study of older participants found accelerated decreases in cognition among individuals hospitalized for SARS-CoV-2 infection, but not nonhospitalized infection, in comparison with individuals not yet infected.